title: No impact of NOD2/CARD15 on outcome after SCT: a reply.
authors.forename: N P
authors.initials: NP
authors.lastname: Mayor
authors.forename: B E
authors.initials: BE
authors.lastname: Shaw
authors.forename: J A
authors.initials: JA
authors.lastname: Madrigal
authors.forename: S G E
authors.initials: SG
authors.lastname: Marsh
mesh_terms: D015331:Cohort Studies; D020022:Genetic Predisposition to Disease; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000235:genetics*; D053473:Nod2 Signaling Adaptor Protein / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D016019:Survival Analysis; D014184:Transplantation, Homologous / Q000009:adverse effects
chemical_list: C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein